Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
3.220
+0.010 (0.31%)
Nov 5, 2024, 12:56 PM EST - Market open

Phio Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Revenue
-----0.02
Upgrade
Revenue Growth (YoY)
------84.78%
Upgrade
Cost of Revenue
6.216.337.018.893.724.3
Upgrade
Gross Profit
-6.21-6.33-7.01-8.89-3.72-4.28
Upgrade
Selling, General & Admin
3.774.294.454.635.084.71
Upgrade
Operating Expenses
2.394.294.454.635.084.71
Upgrade
Operating Income
-8.59-10.62-11.46-13.51-8.79-8.99
Upgrade
Interest Expense
-----0-
Upgrade
Other Non Operating Income (Expenses)
0.12-0-0.02-0.01-0.08
Upgrade
EBT Excluding Unusual Items
-8.47-10.62-11.48-13.52-8.79-8.91
Upgrade
Asset Writedown
-0.13-0.13----
Upgrade
Other Unusual Items
-0.08-0.08-0.23--
Upgrade
Pretax Income
-8.68-10.83-11.48-13.29-8.79-8.91
Upgrade
Net Income
-8.68-10.83-11.48-13.29-8.79-8.91
Upgrade
Net Income to Common
-8.68-10.83-11.48-13.29-8.79-8.91
Upgrade
Shares Outstanding (Basic)
00000-
Upgrade
Shares Outstanding (Diluted)
00000-
Upgrade
Shares Change (YoY)
184.03%83.32%6.30%179.70%--
Upgrade
EPS (Basic)
-21.34-46.76-90.91-111.84-207.04-
Upgrade
EPS (Diluted)
-21.35-46.76-90.91-111.87-207.04-
Upgrade
Free Cash Flow
-9.06-10.75-12.25-11.91-8.82-8.72
Upgrade
Free Cash Flow Per Share
-22.29-46.45-97.00-100.24-207.68-
Upgrade
Operating Margin
------42795.24%
Upgrade
Profit Margin
------42419.05%
Upgrade
Free Cash Flow Margin
------41509.52%
Upgrade
EBITDA
-8.57-10.56-11.39-13.44-8.72-8.92
Upgrade
D&A For EBITDA
0.030.060.070.080.070.07
Upgrade
EBIT
-8.59-10.62-11.46-13.51-8.79-8.99
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.